Summary
IDEXX Laboratories, Inc. (IDXX) filed an 8-K report on May 9, 2024, detailing two primary events: a consulting agreement with a former executive and the results of its 2024 annual shareholder meeting. Effective May 7, 2024, James F. Polewaczyk, formerly an Executive Vice President who retired on April 1, 2024, entered into a one-year consulting agreement. Under this agreement, Mr. Polewaczyk will provide coaching and professional development support to select employees for a fee of $25,000 per month. The annual meeting, held on May 6, 2024, saw shareholders approve all presented proposals. Key outcomes include the election of four Class I directors, the ratification of PricewaterhouseCoopers LLP as the independent registered accounting firm, and an advisory vote to approve executive compensation. Additionally, a shareholder proposal regarding simple majority vote was put to a vote and was approved by a majority of shareholders.
Key Highlights
- 1Former EVP James F. Polewaczyk has entered into a one-year consulting agreement post-retirement, providing coaching and development support for $25,000/month.
- 2The Company's 2024 annual shareholder meeting was held on May 6, 2024.
- 3Shareholders elected Irene Chang Britt, Bruce L. Claflin, Asha S. Collins, PhD, and Sam Samad as Class I directors for terms expiring in 2027.
- 4The appointment of PricewaterhouseCoopers LLP as the independent registered accounting firm for the current fiscal year was ratified by shareholders.
- 5Shareholders provided advisory approval for the compensation of the Company's named executive officers.
- 6A shareholder proposal for a simple majority vote was approved by shareholders.